Interferon-beta downregulates interferon-gamma-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Neuroimmunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7642749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ia antigens in the normal rat nervous system and in lesions of experimental allergic encephalomyelitis

  2004cited by this paper
• The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis

  2004cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells.

  1993cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Ultrastructural localization of factor VIII-related antigen in cultured human brain microvessel endothelial cells.

  1992cited by this paper
• The interferon system. A bird's eye view of its biochemistry.

  1992cited by this paper
• Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth.

  1992cited by this paper
• Modulation of adhesion of lymphocytes to murine brain endothelial cells in vitro: relation to class II major histocompatibility complex expression.

  1992cited by this paper
• Culture and characterization of microvascular endothelial cells derived from human brain.

  1991cited by this paper
• Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal microvascular endothelial cells.

  1991cited by this paper
• Effect of recombinant fibroblast interferon and recombinant immune interferon on growth and the antigenic phenotype of multidrug-resistant human glioblastoma multiforme cells.

  1991cited by this paper
• Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line.

  1991cited by this paper
• Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluation

  1990cited by this paper
• Effect of inflammatory cytokines on human endothelial cell proliferation

  1990cited by this paper
• Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.

  1990cited by this paper
• Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro.

  1990cited by this paper
• Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis.

  1989cited by this paper
• Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

  1989cited by this paper
• Down-regulation of interferon-gamma-induced class II expression on human glioma cells by recombinant interferon-beta: effects of dosage treatment schedule.

  1988cited by this paper
• Major Histocompatibility Complex Molecule Expression in the Human Central Nervous System: Immunohistochemical Analysis of 40 Patients

  1988cited by this paper
• Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are regulated transcriptionally.

  1988cited by this paper
• Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons

  1988cited by this paper
• The Immunopathology of Acute Experimental Allergic Encephalomyelitis. IV. An Ultrastructural Immunocytochemical Study of Class II Major Histocompatibility Complex Molecule (Ia) Expression

  1987cited by this paper
• Inhibition of endothelial cell proliferation by gamma-interferon

  1987cited by this paper
• Treatment of multiple sclerosis with gamma interferon

  1987cited by this paper
• Induction of macrophage Ia antigen expression by rIFN-gamma and down-regulation by IFN-alpha/beta and dexamethasone are mediated by changes in steady-state levels of Ia mRNA.

  1987cited by this paper
• Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared.

  1987cited by this paper
• Multiple sclerosis: relevance of Class I and Class II MHC-expressing cells to lesion development

  1987cited by this paper
• Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens

  1986cited by this paper
• Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells.

  1986cited by this paper
• Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.

  1986cited by this paper
• Therapy of Autoimmune Diseases with Antibody to Immune Response Gene Products or to T‐Cell Surface Markers a

  1986cited by this paper
• The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells.

  1985cited by this paper
• On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation.

  1985cited by this paper
• Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion.

  1985cited by this paper
• Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat.

  1985cited by this paper
• Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.

  1985cited by this paper
• The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration.

  1984cited by this paper
• Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat.

  1984cited by this paper
• Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain

  1981cited by this paper

• Immune and Long Interspersed Nuclear Element-1 Dysregulation in Schizophrenia: An Exploratory Case-Control Study in a Brazilian Cohort with Ultra-Treatment Resistance.

  2025cites this paper
• Cold Atmospheric Plasma: Possible Cure of Autoimmune Disorders and Cancer via Attenuating Inflammation

  2024cites this paper
• An evidence for surface expression of an immunogenic epitope of sarcoplasmic/endoplasmic reticulum calcium-ATPase2a on antigen-presenting cells from naive mice in the mediation of autoimmune myocarditis.

  2019cites this paper
• Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.

  2017cites this paper
• Deciphering the mode of action of drugs used in the treatment of multiple sclerosis

  2016cites this paper
• [Aspects of the innate immune response to intramammary Staphylococcus aureus infections in cattle].

  2014cites this paper
• Aspectos de la respuesta inmune innata en las infecciones intramamarias causadas por Staphylococcus aureus en bovinos

  2014cites this paper
• Mechanisms of Action for Treatments in Multiple Sclerosis

  2012cites this paper
• Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.

  2011cites this paper
• PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

  2010cites this paper
• Overlapping and distinct mechanisms of action of multiple sclerosis therapies.

  2010cites this paper
• Comparative Kinetics of Escherichia coli- and Staphylococcus aureus-Specific Activation of Key Immune Pathways in Mammary Epithelial Cells Demonstrates That S. aureus Elicits a Delayed Response Dominated by Interleukin-6 (IL-6) but Not by IL-1A or Tumor Necrosis Factor Alpha

  2010cites this paper
• High-dose, high-frequency recombinant interferon beta-1a in the treatment of multiple sclerosis.

  2009cites this paper
• Interferon-β stabilizes barrier characteristics of the blood–brain barrier in four different species in vitro

  2008cites this paper
• Neutrophils and the blood–brain barrier dysfunction after trauma

  2007cites this paper
• Aquaporin 1, urea transporters, and renal vascular bundles.

  2007cites this paper
• Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes.

  2007cites this paper
• Spotlight on Interferon-beta-1b in relapsing-remitting and secondary progressive multiple sclerosis.

  2004cites this paper
• Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.

  2004cites this paper
• Biologic role of interferon beta in multiple sclerosis

  2004cites this paper
• Beta Chemokine expression in an in vitro model of the human blood-brain barrier

  2004cites this paper
• The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-beta1a (Rebif).

  2004cites this paper
• Interferon‐β stabilizes barrier characteristics of brain endothelial cells in vitro

  2004cites this paper
• Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro.

  2004cites this paper
• Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

  2002cites this paper
• Multiple sclerosis.

  2002cites this paper
• [Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option?].

  2002cites this paper
• Interferon-beta counteracts inflammatory mediator-induced effects on brain endothelial cell tight junction molecules-implications for multiple sclerosis.

  2002cites this paper
• Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis.

  2001cites this paper
• Major histocompatibility complex class II (MHC II) expression in the normal and pathological human foetal spinal cord.

  2001cites this paper
• A role for interferon-beta in Guillain-Barré Syndrome?

  2000cites this paper
• Interferon beta-1a prevents the effects of lipopolysaccharide on embryonic brain microvessels.

  2000cites this paper
• Major histocompatibility complex class II expression in the frontal and temporal lobes in the human fetus during development.

  2000cites this paper
• Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture.

  2000cites this paper
• Differential induction of chemokines in human microglia by type i and ii interferons

  2000cites this paper
• [Enhanced adherence of endothelial cells to blood mononuclear cells in HAM/TSP].

  1999cites this paper
• Immune functions in untreated and treated multiple sclerosis patients

  1999cites this paper
• Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.

  1999cites this paper
• Decreases in T-cell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis.

  1999cites this paper
• Murine endothelia do not express MHC class II I-Ealpha subunit and differentially regulate I-Aalpha expression along the vascular tree.

  1998cites this paper
• Cytokine‐directed therapies in multiple sclerosis and experimental autoimmune encephalomyelitis

  1998cites this paper
• Cytokine-Induced Inflammation in the Central Nervous System Revisited

  1998cites this paper
• 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon β-1a: results of a preliminary study

  1998cites this paper
• ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha.

  1998cites this paper
• Cytokine-Induced Autoimmune Disorders

  1997cites this paper
• Mechanisms of interferon beta action in multiple sclerosis

  1997cites this paper
• Beta-interferon and multiple sclerosis.

  1997cites this paper
• Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species.

  1997cites this paper
• Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study.

  1997cites this paper
• Glial lineages and myelination in the central nervous system.

  1997cites this paper
• The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion.

  1996cites this paper
• Methylprednisolone attenuates interferon-beta induced expression of HLA-DR on monocytes.

  1996cites this paper
• Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment.

  1996cites this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological Physiology and Anatomy Multiple Sclerosis

  year unknowncites this paper